HOME › DRUGS › ETELCALCETIDE
ACTIVE SUBSTANCE / INN

ETELCALCETIDE

Brand name(s): PARSABIV, Parsabiv
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Hyperparathyroidism, Secondary
NDA208325
ACTIVE SUBSTANCE
Etelcalcetide
REGULATORS
FDA · EMA
SPONSORS / MAH
KAI PHARMS INC, Amgen Europe B.V.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PARSABIVNDA208325KAI PHARMS INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ParsabivAmgen Europe B.V.Authorised11/11/2016Hyperparathyroidism, Secondary

FULL INTELLIGENCE ON ETELCALCETIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →